ALung Initiates Enrollment In Pivotal Trial Of The Hemolung RAS For U.S. Market
Mar 29, 2018 @ 11:28

Study is being conducted under an Investigational Device Exemption received late last year from the FDA.

Sourced through Scoop.it from: www.mpo-mag.com

Leave a Reply